India: Medicaments Containing Insulin Market 2025

Medicaments Containing Insulin Market Size in India

The Indian medicaments containing insulin market rose notably to $X in 2021, increasing by 5.4% against the previous year. Overall, consumption recorded a remarkable increase. Over the period under review, the market attained the peak level at $X in 2016; however, from 2017 to 2021, consumption stood at a somewhat lower figure.

Medicaments Containing Insulin Production in India

In value terms, medicaments containing insulin production amounted to $X in 2021 estimated in export price. In general, production, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2016 with an increase of 12%. As a result, production reached the peak level of $X. From 2017 to 2021, production growth failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from India

Medicaments containing insulin exports from India declined significantly to X tons in 2021, waning by -76.4% on the previous year's figure. In general, exports continue to indicate a dramatic contraction. The most prominent rate of growth was recorded in 2017 with an increase of 131% against the previous year. Over the period under review, the exports reached the maximum at X tons in 2013; however, from 2014 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports shrank remarkably to $X in 2021. Overall, exports continue to indicate a precipitous setback. The pace of growth was the most pronounced in 2017 with an increase of 69% against the previous year. The exports peaked at $X in 2013; however, from 2014 to 2021, the exports failed to regain momentum.

Exports by Country

Iran (X tons) was the main destination for medicaments containing insulin exports from India, accounting for a 75% share of total exports. Moreover, medicaments containing insulin exports to Iran exceeded the volume sent to the second major destination, Pakistan (X kg), ninefold. Qatar (X kg) ranked third in terms of total exports with a 6.9% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Iran totaled -21.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Pakistan (-25.0% per year) and Qatar (-11.8% per year).

In value terms, Iran ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from India, comprising 58% of total exports. The second position in the ranking was held by the United States ($X), with a 25% share of total exports. It was followed by Pakistan, with a 6.4% share.

From 2012 to 2021, the average annual growth rate of value to Iran stood at -43.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (-39.7% per year) and Pakistan (-46.5% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, waning by -31% against the previous year. In general, the export price continues to indicate a sharp downturn. The most prominent rate of growth was recorded in 2015 when the average export price increased by 47%. Over the period under review, the average export prices reached the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major foreign markets. In 2021, amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Qatar ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+0.4%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into India

In 2021, imports of medicaments containing insulin but not antibiotics into India soared to X tons, picking up by 259% on 2020. Over the period under review, imports continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 with an increase of 8,947%. Imports peaked at X tons in 2013; however, from 2014 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports soared to $X in 2021. In general, imports, however, showed a slight curtailment. The most prominent rate of growth was recorded in 2015 with an increase of 13,794% against the previous year. Imports peaked at $X in 2013; however, from 2014 to 2021, imports failed to regain momentum.

Imports by Country

The United States (X tons) and Australia (X tons) were the main suppliers of medicaments containing insulin imports to India.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Australia (with a CAGR of +650.9%).

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to India, comprising 98% of total imports. The second position in the ranking was taken by Australia ($X), with a 2% share of total imports.

From 2012 to 2021, the average annual growth rate of value from the United States stood at -1.4%.

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, waning by -33.9% against the previous year. Over the period under review, the import price continues to indicate a mild downturn. The pace of growth appeared the most rapid in 2018 an increase of 58% against the previous year. Over the period under review, average import prices reached the maximum at $X per ton in 2016; however, from 2017 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per ton), while the price for Australia stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (+4.9%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :